National Lab Briefs

Pity the planners at the Los Alamos Meson Physics Facility. After 25 years operating one of the nation’s top experimental accelerators, LAMPF officials fear that their operation may fall victim to the Energy Department’s desire to attract international partners for the superconducting supercollider. Both LAMPF and a similar Canadian meson physics facility in British Columbia want to upgrade their accelerators to the tune of several hundred million dollars—and it appears likely


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Pity the planners at the Los Alamos Meson Physics Facility. After 25 years operating one of the nation’s top experimental accelerators, LAMPF officials fear that their operation may fall victim to the Energy Department’s desire to attract international partners for the superconducting supercollider. Both LAMPF and a similar Canadian meson physics facility in British Columbia want to upgrade their accelerators to the tune of several hundred million dollars—and it appears likely that only the Canadians will get the nod from DOE. Last month, the Canadian science ministry agreed to fund an $11 million feasibility study (with the goal of completing construction by 1993), and the proposal calls for substantial financial support from DOE. Why funnel U.S. dollars into Canadian high-energy physics? It is a ‘good quid pro quo for the Canadians getting in on the SSC,” explains Richard Orr, a Fermilab scientist who is familiar with the project.

Such a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio